http://www.biocangen.com Diagnostic Technologies at the Cutting Edge Wed, 26 Sep 2007 22:08:43 +0000 http://backend.userland.com/rss092 en NEW YORK, New York (January 10, 2007) - BioCangen Inc. announced that the initial clinical validation study of early cancer detection using Methylplusâ„¢, the non-invasive assay kit based on USGMAT, has been successfully completed. Among the blood samples from 102 patients with solid tumors including lung cancer, colon cancer, breast ... http://www.biocangen.com/?p=10 NEW YORK, New York (March 28 , 2005) - BioCangen announced today that BioCangen begins clinical trials to evaluate USGMAT, an innovative technology for early cancer detection, by collaborating with China-based Walkman Biomaterials, Ltd. The USGMAT detects cancer by identifying methylation alterations of a panel of the tumor-specific genes using ... http://www.biocangen.com/?p=3 New York, NEW YORK (February 21, 2005) -- BioCangen announces the establishment of the Ultra-Sensitive Gene Methylation Array Technology (USGMAT). The major advantages of the USGMAT include (1) high accuracy and sensitivity for quantitative measurements of DNA methylation; (2) the usage of only tiny amounts of DNA from blood or ... http://www.biocangen.com/?p=4